Scott Dylla
Direktor/Vorstandsmitglied bei KINETA, INC.
Vermögen: 2 560 $ am 30.04.2024
Profil
Scott J.
Dylla is the founder of Stemcentrx, Inc. which was founded in 2008.
He held the title of Director & Chief Scientific Officer at Stemcentrx, Inc. Dr. Dylla's current job positions include Chairman at Driver Bioengineering, Inc. since 2019, Director at 3D Bio Holdings, Inc. since 2020, and Independent Director at Kineta, Inc. starting in 2023.
Dr. Dylla's education history includes an undergraduate degree from the University of Minnesota and a graduate degree from The University of Alabama at Birmingham.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
KINETA, INC.
0,04% | 25.04.2024 | 4 000 ( 0,04% ) | 2 560 $ | 30.04.2024 |
Aktive Positionen von Scott Dylla
| Unternehmen | Position | Beginn |
|---|---|---|
| KINETA, INC. | Direktor/Vorstandsmitglied | 01.07.2023 |
Driver Bioengineering, Inc.
 Driver Bioengineering, Inc. Medical SpecialtiesHealth Technology Driver Bioengineering, Inc. develops modular, drug-responsive, titratable, ribozyme based control devices for chimeric antigen receptor. It engages in building control systems for chimeric antigen receptor (CAR) T-cell therapeutics. The company was founded by Gusti Zeiner, Christina Smolke and Benjamin Wang on May 12, 2015 and is headquartered in Menlo Park, CA. | Vorsitzender | 01.06.2019 |
3D Bio Holdings, Inc.
 3D Bio Holdings, Inc. Packaged SoftwareTechnology Services 3D Bio Holdings, Inc. develops term clinical applications. It focuses on whole tissue living implants. The company was founded by Hod Lipson, Larry Bonassar and Daniel L. Cohen and is headquartered in Brooklyn, NY. | Direktor/Vorstandsmitglied | 30.10.2020 |
Ehemalige bekannte Positionen von Scott Dylla
| Unternehmen | Position | Ende |
|---|---|---|
Stemcentrx, Inc.
 Stemcentrx, Inc. BiotechnologyHealth Technology Stemcentrx, Inc. develops life-changing therapies for cancer patients. It develops proprietary discovery platforms that yield unprecedented insight into the biology of tumors and are being exploited to develop potent new cancer drugs. The firm specializes in designing drugs to target cancer stem cells, which are the cells that cause cancer to spread throughout the body. The company was founded by Brian Christopher Slingerland, Daniel T. Reiner and Scott J. Dylla in 2008 and is headquartered in San Francisco, CA. | Gründer | - |
Ausbildung von Scott Dylla
| University of Minnesota | Undergraduate Degree |
| The University of Alabama at Birmingham | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| KINETA, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Stemcentrx, Inc.
Stemcentrx, Inc. BiotechnologyHealth Technology Stemcentrx, Inc. develops life-changing therapies for cancer patients. It develops proprietary discovery platforms that yield unprecedented insight into the biology of tumors and are being exploited to develop potent new cancer drugs. The firm specializes in designing drugs to target cancer stem cells, which are the cells that cause cancer to spread throughout the body. The company was founded by Brian Christopher Slingerland, Daniel T. Reiner and Scott J. Dylla in 2008 and is headquartered in San Francisco, CA. | Health Technology |
Driver Bioengineering, Inc.
Driver Bioengineering, Inc. Medical SpecialtiesHealth Technology Driver Bioengineering, Inc. develops modular, drug-responsive, titratable, ribozyme based control devices for chimeric antigen receptor. It engages in building control systems for chimeric antigen receptor (CAR) T-cell therapeutics. The company was founded by Gusti Zeiner, Christina Smolke and Benjamin Wang on May 12, 2015 and is headquartered in Menlo Park, CA. | Health Technology |
3D Bio Holdings, Inc.
3D Bio Holdings, Inc. Packaged SoftwareTechnology Services 3D Bio Holdings, Inc. develops term clinical applications. It focuses on whole tissue living implants. The company was founded by Hod Lipson, Larry Bonassar and Daniel L. Cohen and is headquartered in Brooklyn, NY. | Technology Services |